
HSBC Slashes Eli Lilly Price Target, Warns Obesity Drug Market Vastly Overhyped
HSBC downgraded $LLY to Reduce, citing inflated obesity market projections. The analyst sees $80-120B market by 2032, not Wall Street's $150B estimate.
LLYNVOprice target cutmarket valuation

